Rapid exacerbation of multiple sclerosis following the initiation of interferon-β: report of nine cases

Background: Interferon-β (IFN-β) is an effective drug in multiple sclerosis (MS) but it may cause acute exacerbation of MS following the initiation of treatment. This study evaluated patients with rapid exacerbation of multiple sclerosis (REMS) following the initiation of IFN-β. Methods: We retrospe...

Full description

Bibliographic Details
Main Authors: Masoud Etemadifar, Amir Hossein Sarrami
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2011-01-01
Series:Journal of Research in Medical Sciences
Subjects:
Online Access:http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2011;volume=16;issue=12;spage=1619;epage=1622;aulast=Etemadifar